{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:55:20Z","timestamp":1789419320059,"version":"build-2803163510"},"reference-count":32,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"6","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:p>Background: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterised by impaired glucose metabolism, which necessitates comprehensive management of blood glucose (BG), blood pressure, and lipid profiles. This study aimed to evaluate the clinical effects of individualised nutrition and insulin pump therapy, guided by continuous glucose monitoring (CGM) and the Quality Circle Control (QCC) nursing model, on various biomarkers in T2DM patients, including fasting C-peptide (FC-P), fasting plasma glucose (FPG), 2-hour postprandial glucose (2hPG), fasting insulin (FIns), and glycated haemoglobin (HbA1c). Methods: Eighty T2DM patients treated at our hospital were enrolled in the study between January 2023 and January 2024. Patients were assigned to either the experimental group (EG), which received individualised nutrition and insulin pump therapy supported by CGM and the QCC nursing model, or the regular group (RG), which received standard care. Differences in BG control, insulin usage, CGM system performance (including downtime and anomaly rates), and patient satisfaction were compared between the two groups. Results: The EG demonstrated significant improvements in FC-P, FPG, 2hPG, FIns, and HbA1c levels compared to the RG (P&lt;0.05). Specifically, the EG showed more rapid achievement of BG targets, reduced glucose variability, lower insulin usage, and decreased CGM system anomalies. Conclusions: The QCC nursing model, when integrated with individualised nutrition and insulin pump therapy guided by CGM, significantly enhances blood glucose control, optimises insulin therapy, and improves patient outcomes, including dietary habits, quality of life, and reduction in hypoglycemic events. This model shows promise as an effective strategy for managing T2DM and warrants further adoption in clinical practice.<\/jats:p>","DOI":"10.5937\/jomb0-55738","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T03:03:10Z","timestamp":1744167790000},"page":"1288-1296","source":"Crossref","is-referenced-by-count":2,"title":["Serum value of fasting C-peptide (FC-P), fasting insulin (FIns), and glycated hemoglobin (HbA1c) after dynamic blood glucose monitoring-guided personalised nutrition and insulin pump therapy for type II diabetes mellitus"],"prefix":"10.5937","volume":"44","author":[{"given":"Qing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3964","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022; 183: 109119;","DOI":"10.1016\/j.diabres.2021.109119"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Zhang X, Yang XL, Liu S, Ye YS, Yang QT, Xia LN. Prevalence of hypertension among type 2 diabetes mellitus patients in China: a systematic review and meta-analysis. Int Health 2024; 16(2): 144-51;","DOI":"10.1093\/inthealth\/ihad047"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Marinovi\u0107 S, Cigrovski Berkovi\u0107 M, Zja\u017ei}-Rotkvi\u0107 V, Kapitanovi\u0107 S. Analysis of polymorphisms in EGF, EGFR and HER2 genes in pancreatic neuroendocrine tumors (PNETs). Cancer Genet 2022; 266-7: 44-50;","DOI":"10.1016\/j.cancergen.2022.06.005"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Liu G, Li Y, Pan A, Hu Y, Chen S, Qian F, et al. Adherence to a Healthy Lifestyle in Association With Microvascular Complications Among Adults With Type 2 Diabetes. JAMA Netw Open 2023; 6(1): e2252239;","DOI":"10.1001\/jamanetworkopen.2022.52239"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Pi L, Zheng Y, Shi X, Wang Z, Zhou Z. Using point-of-care HbA1c to facilitate the identification of diabetes and abnormal glucose regulation in primary healthcare settings. Front Public Health 2023; 11: 1078361;","DOI":"10.3389\/fpubh.2023.1078361"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Zelada H, Perez-Guzman MC, Chernavvsky DR, Galindo RJ. Continuous glucose monitoring for inpatient diabetes management: an update on current evidence and practice. Endocr Connect 2023; 12(10): e230180;","DOI":"10.1530\/EC-23-0180"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Sch\u00fctz-Fuhrmann I, Rami-Merhar B, Fr\u00f6hlich-Reiterer E, Hofer SE, Tauschmann M, Mader JK, et al. Diabete-technologie (Update 2023) (Insulin pump therapy and continuous glucose monitoring). Wien Klin Wochenschr 2023; 135(Suppl 1): 53-61;","DOI":"10.1007\/s00508-023-02165-9"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Grunberger G, Sherr J, Allende M, Blevins T, Bode B, Handelsman Y, et al. American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus. Endocr Pract 2021; 27(6): 505-37;","DOI":"10.1016\/j.eprac.2021.04.008"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Ekanayake P, Edelman S. Identifying patients with type 2 diabetes who might benefit from insulin pump therapy: Literature review, clinical opportunities, potential benefits and challenges. Diabetes Obes Metab 2023; 25 Suppl 2: 3-20;","DOI":"10.1111\/dom.15059"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Wang Y, Lai Y, Du L, Shen W. Impact of Quality Control Circle on Patient Outcomes after Hepatocellular Carcinoma Intervention: A Meta-Analysis. Expert Rev Anticancer Ther 2023; 23(8): 875-82;","DOI":"10.1080\/14737140.2023.2219899"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Zhu YT, Jiang YX, Pei L, Zhu WC, Jin XG. Application of quality control circle in the management of early ambulation after cesarean section: An observational study. Medicine (Baltimore) 2024; 103(14): e37633;","DOI":"10.1097\/MD.0000000000037633"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Jia W, Weng J, Zhu D, Ji L, Lu J, Zhou Z, et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev 2019; 35(6): e3158;","DOI":"10.1002\/dmrr.3158"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Li H, Chang GY, Jiang YH, Xu L, Shen L, Gu ZC, et al. System Dynamic Model Simulates the Growth Trend of Diabetes Mellitus in Chinese Population: Implications for Future Urban Public Health Governance. Int J Public Health 2022; 67: 1605064;","DOI":"10.3389\/ijph.2022.1605064"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Kim KS, Hong S, Han K, Park CY. Association of non-alcoholic fatty liver disease with cardiovascular disease and all-cause death in patients with type 2 diabetes mellitus: nationwide population-based study. BMJ 2024; 384: e076388;","DOI":"10.1136\/bmj-2023-076388"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Lui DTW, Chung MSH, Lau EHY, Lau KTK, Au ICH, Lee CH, et al. Analysis of all-cause hospitalisation and death among nonhospitalised patients with type 2 diabetes and SARS-CoV-2 infection treated with molnupiravir or nirmatrelvir-ritonavir during the Omicron wave in Hong Kong. JAMA Netw Open 2023; 6(5): e2314393;","DOI":"10.1001\/jamanetworkopen.2023.14393"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Li Y, Liu H. Clinical powers of Aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 1 (AIMP1) for head-neck squamous cell carcinoma. Cancer Biomark 2022; 34(3): 359-374;","DOI":"10.3233\/CBM-210340"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Ou L, Liu HR, Shi XY, Peng C, Zou YJ, Jia JW, et al. Terminalia chebula Retz. aqueous extract inhibits the Helicobacter pylori-induced inflammatory response by regulating the inflammasome signaling and ER-stress pathway. J Ethnopharmacol 2024; 320: 117428;","DOI":"10.1016\/j.jep.2023.117428"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Holzer R, Bloch W, Brinkmann C. Continuous glucose monitoring in healthy adults - Possible applications in health care, wellness, and sports. Sensors (Basel) 2022; 22(5): 2030;","DOI":"10.3390\/s22052030"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Saha T, Del Ca\u00f1o R, Mahato K, De la Paz E, Chen C, Ding S, et al. Wearable electrochemical glucose sensors in diabetes management: A comprehensive review. Chem Rev 2023; 123(12): 7854-89;","DOI":"10.1021\/acs.chemrev.3c00078"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Zhao H, Hu M, Cao Y, Wu X, Zhu F. Study on the application of quality control circle activity in postoperative nursing of elderly dental implants. Medicine (Baltimore). 2024; 103(2): e36894;","DOI":"10.1097\/MD.0000000000036894"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Ye H, Feng X, Hu X, Zheng S, Zheng L. The application effect of using quality control circle management to improve the quality of nursing in operating rooms. Panminerva Med 2023;","DOI":"10.23736\/S0031-0808.23.04967-4"},{"key":"ref22","unstructured":"Chen X, Shen H, Zhang M. Analysis of effect of quality control circle management model on the error rate of disposable item distribution and efficiency of medical workers in sterilisation supply center. Altern Ther Health Med 2024; 30(2): 102-5;"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Sasaki R, Taura N, Nakao Y, Fukushima M, Haraguchi M, Miuma S, et al. Hypoglycemia measured by flash glucose monitoring system predicts liver-related events in chronic liver disease patients. Sci Rep 2023; 13(1): 13791;","DOI":"10.1038\/s41598-023-40910-2"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Grady M, Cameron H, Bhatiker A, Holt E, Schnell O. Real-world evidence of improved glycemic control in people with diabetes using a Bluetooth-connected blood glucose meter with a mobile diabetes management app. Diabetes Technol Ther 2022; 24(10): 770-8;","DOI":"10.1089\/dia.2022.0134"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Lanzinger S, Best F, Bergmann T, Laimer M, Lipovsky B, Danne T, et al. Dynamics of hemoglobin A1c, body mass index, and rates of severe hypoglycemia in 4434 adults with type 1 or type 2 diabetes after initiation of continuous glucose monitoring. Diabetes Technol Ther 2022; 24(10): 763-9;","DOI":"10.1089\/dia.2022.0063"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Thomas F, Signal M, Chase JG. Using continuous glucose monitoring data and detrended fluctuation analysis to determine patient condition: A review. J Diabetes Sci Technol 2015; 9(6): 1327-35;","DOI":"10.1177\/1932296815592410"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2022; 65(12): 1925-66;","DOI":"10.1007\/s00125-022-05787-2"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Hornsten A, Lundman B, Selstam EK, Sandstrom H. Patient satisfaction with diabetes care. J Adv Nurs 2005; 51(6): 609-17;","DOI":"10.1111\/j.1365-2648.2005.03546.x"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Ortiz-Mart\u00ednez M, Gonz\u00e1lez-Gonz\u00e1lez M, Martag\u00f3n AJ, Hlavinka V, Willson RC, Rito-Palomares M. Recent developments in biomarkers for diagnosis and screening of type 2 diabetes mellitus. Curr Diab Rep 2022; 22(3): 95-115;","DOI":"10.1007\/s11892-022-01453-4"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Dixon JB, Dixon AF, O'Brien PE. Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment. Diabet Med 2003; 20(2): 127-34;","DOI":"10.1046\/j.1464-5491.2003.00889.x"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Berget C, Messer LH, Forlenza GP. A clinical overview of insulin pump therapy for the management of diabetes: Past, present, and future of intensive therapy. Diabetes Spectr 2019; 32(3): 194-204;","DOI":"10.2337\/ds18-0091"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Wagner J, Tennen H, Wolpert H. Continuous glucose monitoring: A review for behavioral researchers. Psychosom Med 2012; 74(4): 356-65;","DOI":"10.1097\/PSY.0b013e31825769ac"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Serumske vrednosti C-peptida (FC-P), insulina (FIns) i glikoziliranog hemoglobina (HbA1c) nakon personalizovane ishrane glukozom i terapije insulinskom pumpom u krvi kod Dijabetes melitusa tipa II"],"language":"en","link":[{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2025\/1452-82582506288Z.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T11:15:43Z","timestamp":1757070943000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582506288Z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-55738","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"value":"1452-8258","type":"print"},{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}